NuVasive, Inc. (NUVA) News Headlines

▮ More

Date

Headline

6/17/2019 8:33:42 AM NuVasive Announces Commercial Launch Of Modulus® TLIF-O

5/1/2019 4:13:52 PM NuVasive, Inc. Q1 adjusted earnings of $0.53 per share

5/1/2019 4:07:25 PM NuVasive Q1 EPS $0.18 S. Loss $0.53 Year Ago

5/1/2019 3:00:17 PM NuVasive Q1 19 Earnings Conference Call At 4:30 PM ET

4/11/2019 5:31:35 AM NuVasive To Introduce X360 System Integrated With Pulse For Lateral Single-position Surgery At AANS

2/21/2019 12:15:04 AM FDA Places XNCR Trial On Hold, ABIO Abuzz, Mark Your Calendar For SRPT

2/20/2019 4:07:04 PM NuVasive, Inc. Q4 adjusted earnings Beat Estimates

2/20/2019 4:03:16 PM NuVasive Q4 GAAP EPS $0.23; Non-GAAP EPS $0.69

2/20/2019 3:00:16 PM NuVasive, Q4 18 Earnings Conference Call At 4:30 PM ET

2/9/2019 5:45:48 AM FT: Smith & Nephew In Talks To Buy NuVasive For Over $3 Bln

1/7/2019 8:49:53 AM NuVasive Sees Higher Revenue In 2018

1/7/2019 8:32:49 AM NuVasive Expects Q4 Revenue To Be $288 Mln And 2018 Revenue Of About $1.102 Bln

1/3/2019 8:32:40 AM NuVasive Announces New Organizational Structure

11/29/2018 8:32:42 AM NuVasive To Participate In Piper Jaffray Healthcare Conference At 9:30 AM ET

10/30/2018 4:56:37 PM NuVasive, Inc. (NUVA) Has Lowered Its 2018 EPS Estimate To 2.15 - 2.23 From 2.37 - 2.40

10/30/2018 4:55:05 PM NuVasive, Inc. (NUVA) Has Raised Its 2018 Revenue Estimate To $1.105 - $1.110 Bln From $1.095 - $1.105 Bln

10/30/2018 4:53:39 PM NuVasive, Inc. Q3 adjusted earnings Miss Estimates

10/30/2018 4:05:13 PM NuVasive Q3 EPS $0.30 Vs. $0.64 Year Ago

10/19/2018 8:41:46 AM NuVasive Appoints Christopher Barry To Succeed Gregory Lucier As CEO

10/19/2018 8:31:05 AM NuVasive Names Christopher Barry To Succeed Gregory Lucier As CEO; Lucier To Remain Chairman Of Board

Nuvasive, Inc. (NUVA)